when will compounding pharmacies have to stop making tirzepatide FDA shut down compounded tirzepatide? US judge denies injunction, restricting

Typical SubQ injections doses are small, often around 1 mL or less, unless directed otherwise

Jody Dushay, an endocrinologist at Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School, said she doesnt support the use of compounded GLP-1 drugs but also worries that restrictions could add new strain to the overall supply

Tsvetkov P, Detappe A, Cai K, Keys HR, Brune Z, Ying W, et al

Thyroid-specific considerations: Although there is no established link between GLP-1 receptor agonists and Graves disease or hyperthyroidism, patients should be aware of thyroid-related warnings